Prakiraan wutah bathi kanggo taun ngarep Daxor Corp. (DXR)

Daxor Corp (DXR) - logo korporat

Daxor Corporation management aims to integrate precise blood measurements into medical standards. The projected net profit growth for Daxor Corporation on the GURU.Markets chart reflects the dynamics of these efforts, where 85.80 shows the current value of the metric. Growth is driven by efficient express delivery of test kits via diversified logistics, while business security is ensured by in-house equipment production combined with the outsourcing of basic consumable supplies.

DXR: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Daxor Corp 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Daxor Corporation

- rega lan prakiraan konsensus rega:
Analisis dhasar perusahaan:DXR, Daxor
Produk dadi Daxor

The fundamental valuation of an asset depends directly on market expectations regarding future cash flows. This indicator measures the aggregated forecast of net profit growth rates, reflecting analysts' belief in business scalability through a history of consensus earnings estimates for the coming year. For Daxor Corporation (DXR), this metric confirms the effectiveness of its patent protection and monopoly position within US clinics during rigorous FDA audits.

Pesaing wigati

Prakiraan wutah bathi resik saben saham kanggo taun ngarep abbott.com|Prakiraan wutah bathi saben saham kanggo taun ngarep Thermo Fisher Scientific (TMO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep GE HealthCare Technologies Inc. (GEHC)|MTD - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep WAT (Waters Corporation)|Techne Corporation (TECH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Bruker - Prakiraan wutah bathi kanggo taun ngarep|AZTA (Azenta, Inc.) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|VREX: Prakiraan wutah bathi kanggo taun ngarep|SMLR - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|BFLY (Butterfly Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Mesa Labs Corp (MLAB)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Quantum-Si (QSI)|Prakiraan wutah bathi kanggo taun ngarep nanox.vision (NNOX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Quanterix QTRX|908 Devices Corp - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CV - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep MXCT (MaxCyte, Inc)|RPID: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep seer.bio (SEER)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep hyperfine.io|FONR - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep MDAI (Spectral AI Inc.)|Prakiraan wutah bathi kanggo taun ngarep Organovo Holdings (VIVS)|Prakiraan wutah bathi kanggo taun ngarep ACON (aclarion.com)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Akoya Biosciences (AKYA)|THMO - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TLIS|T2 Biosystems Inc (TTOO) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep